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Abstract
Neonates are highly susceptible to infectious diseases and defective antiviral pDC immune responses have been proposed
to contribute to this phenomenon. Isolated cord blood pDCs innately responded to a variety of TLR7 and TLR9 dependent
viruses, including influenza A virus (IAV), human immunodeficiency virus (HIV) or herpes-simplex virus (HSV) by efficiently
producing IFN-a, TNF-a as well as chemokines. Interestingly, following activation by CpGA, but not viruses, cord pDCs tend
to survive less efficiently. We found that a hallmark of pDCs in neonates is an extended CD2+pDCs compartment compared
to adult pDCs without affecting the antiviral IFN-a response. Within CD2+pDCs, we identified a subpopulation expressing
CD5 and responsible for IL-12p40 production, however this population is significantly decreased in cord blood compared to
adult blood. Therefore, neonatal pDCs clearly display variation in phenotype and subset composition, but without major
consequences for their antiviral responses.
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Introduction
How the immune system in early infancy accommodates
pathogens is poorly defined and requires assessment to contrive
and improve treatments and vaccines [1]. Newborns are
considered to have defective innate immunity, possibly due to
reduced inflammatory responses of innate cells to Toll-like
receptor (TLR) activation [2] and limited or impaired antigen-
presenting cell functions [3]. Studies showed an age-dependent
maturation of the IL-12/IFN–c response [4,5]. In humans, cell
intrinsic epigenetic regulation has been shown to impair the
capacity of cord monocyte derived DCs (MoDCs) to produce IL-
12 in response to LPS [6]. MoDCs also showed a limited IL-12
response to cytomegalovirus (CMV), although efficient T cell
responses develop upon congenital CMV infection [7]. Exceptions
exist with TLR7/8 agonists potently activating monocytes for
TNF-a production [8].
Viral diseases are a major cause of mortality and morbidity in
young children [1], and pDCs potently produce antiviral IFN-a in
response to viruses mainly via two major innate recognition
receptors of viral nucleic acid, TLR7 and TLR9 [9]. Neonatal
murine studies indicate that the dendritic cell compartment
including pDCs in lymphoid organs is not intrinsically impaired
for innate and antigen-presenting cell (APC) functions [10,11,12].
However, pDCs isolated from cord blood have been shown to be
defective for CpGA/TLR9 activation due to a limited IRF7
nuclear translocation [13,14]. Fine tuning of different DCs signals
vary depending on the pathogen [15], we thus reinvestigated this
issue by extending the study of pDC activation by RNA viruses
recognized through TLR7, including IAV [16] and HIV [17] and
we further analyzed pDC subsets and phenotypes in neonates.
Materials and Methods
Blood and ethics statement
Heparinized cord blood samples processed within 24 h were
collected from healthy full-term neonates (gestation time from 37
to 41 weeks) from Maternity Port Royal and Bichat, both in Paris
area, between 2007 and 2010. Buffy coats from 18–60 year-old
donors were obtained from the EFS. This study was carried out
with the approval of Institut Pasteur Review Board qualified for
Medical research and the French Regional Ethics Committee CPP
IDF IV in agreement with the principles of the declaration of
Helsinki. Written consent was obtained from the mother. Ethnic
origin of cord blood donors was not available, but as a reference
the geographical origins of children born in 2009 in the maternity
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was as follows : 48% from Europe, 14% from North Africa, 19%
from Sub-Saharan Africa, 5% from Asia. Ethnic origin of adult
donors was not available, and all blood samples were collected in
Paris area.
Media and reagents
Medium was RPMI-1640 with 5–10% fetal calf serum (ICN
Biomedicals, Inc.), 561025 M of 2-Mercaptoethanol (Sigma), and
antibiotics (penicillin 100 U/ml, streptomycin 100 mg/ml,
GIBCO BRL). TLR9 agonists CpGA (2216, 59-GGGGAC-
GATCGTCGGGGGG-39) was synthesized by Sigma. Influenza
virus strain A/PR8/1976 (H1N1) was from Charles River
Laboratories and used as IAV (live) or HI-IAV (heat-inactivated).
Stocks of HSV-1 (Shealy) were prepared from supernatants of
infected Vero cells cultured in RPMI–2% FCS for 72 h p.i. at an
m.o.i. of 0.1 and had a titer of 106 to 107 PFU/ml. For HIV,
primary cells were cocultured with infected MT4C5 T cells (105/
ml). HI-IAV was obtained by treating the virus at 56uC for 1 hr.
IL-3 and GMCSF were from R&D. Antibodies against CD1c,
CD2, CD5, CD14, CD20, CD40, CD45RA, CD86, CD123 and
HLADR were from eBioscience, BDCA2 and IFN-a from
Miltenyi Biotec, IL-12 p40 from BD Biosciences.
Cell purification and analysis
Mononuclear cells (MNC) were separated from granulocytes,
erythrocytes, and platelets by gradient fractionation (Lymphoprep
Axis-Shield). pDCs were isolated from CBMCs (cord blood
mononuclear cells) or adult PBMCs (peripheral blood mononu-
clear cells) by using anti–BDCA-4 magnetic beads (Miltenyi
Biotec) according to the manufacture’s protocol. In short, 100 ml
magnetic beads were used for 108 cells in a volume of 500 ml buffer
(PBS containing 1% fetal calf serum, 2.5 mM EDTA). After
incubation at 4uC for 15min, cells were washed and run on
autoMACS Pro (Miltenyi Biotec) by using possels program).
Enriched pDCs were further sorted as CD123hiCD45RA+ by flow
cytometry on FACSAria (BD Biosciences). In general, 2–36105
and 5–106105 pDCs were sorted from one cord blood and one
buffy coat, respectively. In some experiments, pDCs were further
Figure 1. Innate responses of cord blood pDCs to viruses. Adult or neonatal whole blood (WB) (A and C), mononuclear cells (MNC) (A and C)
or purified pDCs (A–C) were stimulated with CpGA (50 mg/ml for WB, 5 mg/ml for others in A), live IAV (1000 HAU/ml for WB, 10 HAU/ml for others),
heat-inactivated IAV (HI-IAV in C) live HIV (105 infected T cells in A) and live HSV-1 (106 pfu/ml in A) for 24 hrs. Plasma or supernatants were collected
and tested for IFN-a (A and C) or TNF-a, CCL3 and CCL4 (B). NA: non applicable. The number of donors is indicated for each group (n) as well as P
values for adults and neonates comparison. In B, n = 8 for adult and n=7 for neonates.
doi:10.1371/journal.pone.0052003.g001
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sorted as CD2+ and CD22. Purified pDCs and subsets were
routinely more than 99% pure.
To measure the frequency of pDCs, pDC subsets or their
phenotypes, 106 to 36106 CBMCs or PBMCs were stained and
analyzed. Cells were stained with optimally diluted fluorochrome-
conjugated antibodies at room temperature for 10 minutes. Then
the cells were acquired on CyAn (Beckman Coulter) and analyzed
by Flowjo software (Tree Star) with computed compensation. At
least 104 pDCs were gated for analysis.
To measure the survival rate of stimulated pDC, purified pDCs
stimulated for 24 hrs were washed twice with PBS and stained
with Annexin V Apoptosis detection Kit (BD Biosciences)
according to the manufacture’s instructions. Cells were acquired
on CyAn and analyzed as above.
Innate activation and Cytokine Measurement
Fresh WB, 56105 MNC or 104 purified pDCs were plated in
96-well flat-bottom plates (WB and MNC in a volume of 250 ml) or
Figure 2. Cord blood pDCs are the main contributor for IFN-a response. (A) Neonatal cord blood was left untreated or exposed to IAV, for
6 hrs and stained intracellularly for IFN-a. pDCs are identified by CD123 and BDCA4 and monocytes by CD14 expression. (B) Total CBMC (1), or CBMC
depleted of pDCs (2) or of monocytes (3) were stimulated with CpGA, live IAV and HI-IAV as in Fig. Plasma or supernatants were collected and tested
for IFN-a (A). Depletion efficiency is shown for pDCs identified by CD123 and CD45RA and monocytes by CD14 and CD11b expression. One
experiment representative of three is shown.
doi:10.1371/journal.pone.0052003.g002
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U-bottom plates (pDCs in a volume of 200 ml) for stimulation.
Plasma or supernatants were collected at 24 hrs and kept frozen at
280uC until detection. IFN-a, TNF-a, CCL3 and CCL4 were
measured by a Multiplex kit (Luminex assay, Biosource) according
to the manufacture’s instructions. Briefly, appropriately diluted
samples were distributed into 96-well luminex plate and incubated
with fluorescent beads which were coated with first antibody
recognizing individual cytokine or chemokine for 1 hr at room
temperature with shaking (500 RPM). After washing 3 times,
secondary biotin antibodies were added and the plate was further
incubated at room temperature for 1 hr with shaking (500 RPM).
After washing 3 times, streptavidin phycoerythrin was added and
incubated for 10 min at room temperature. The plate was washed
for another 3 times and the beads were resuspended in running
buffer and acquired on a Luminex 6100 machine by using the
Starstation software (Applied Cytometry).
Intracellular cytokine analyses
MNCs were stimulated as indicated for 6 hrs, GolgiPlug (BD
Biosciences, 1:1000 dilution) was added in the culture for the last
3 hrs. Cells were harvested, fixed and permeabilized by using the
Cytofix/Cytoperm kit (BD Biosciences). Briefly, cells were first
fixed in fixation/permeabilization solution for 20 min at 4uC.
Following 2 wahsing steps with the permeabilization/washing
solution, cells were stained with optimal concentrations of
fluorochrome-conjugated antibodies against IFN-a or IL-12 p40
in the permeabilization/washing solution for 30 min at 4uC. After
washing 3 times, cells were resuspended in PBS containing 1%
fetal calf serum and acquired on CyAn (Beckman Coulter) and
analyzed by Flowjo software (Tree Star). At leat 104 targeted cells
(for instance, at lease 104 pDCs were acquried from MNCs if
pDCs were the target cells.) were acquired for analysis.
Statistical analysis
Unpaired t test was used for comparison of two groups of data
presented as mean value6 SD. P values of,0.05 were considered
statistically significant.
Results and Discussion
We first sought to analyze the antiviral IFN-a response of cord
blood cells to TLR7 dependent IAV [16] and HIV [17] as well as
in response to TLR9 dependent HSV [18] and CpGA activation
(Fig. 1). High levels of IFN-a secretion were observed in all
conditions for neonatal whole blood and CBMC. No statistical
differences were observed between neonatal and adult samples for
all virus stimulation, but CpG/TLR9 displayed discrepancies.
Neonatal pDCs were shown to be defective for IFN-a response to
CpG/TLR9 activation, but these early studies were performed
with pDCs of 50% purity [14]. pDCs can be clearly identified by
the expression of BDCA4 and BDCA2, as well as the high
expression of CD45RA and CD123. Therefore we further
investigated functions of cord blood pDCs to .99% purity by
magnetic bead enrichement of BDCA4 cells followed by FACS
sorting on CD123 and CD45RA expression (Fig. S1) and then
exposed these cells to viruses. pDCs purified from adult and
neonatal blood responded similarly (Fig. 1A). These IFN-a
responses along with the production of TNF-a and chemokines
were as efficient as those obtained with adult samples, except for
CpGA/TLR9 activation (Fig. 1B). We observed similar IFN-a
responses to heat inactivated IAV in adult and neonatal samples
tested as WB, MNC and purified pDCs (Fig. 1C). For neonatal
whole blood exposed to live IAV, pDCs were mainly responsible
for IFN-a secretion, whereas monocyte only poorly contributed to
this response (Fig. 2A). Similarly, following depletion of pDCs, but
not ofmonocytes, neonatal MNC were strongly impaired or
decreased in their capacity to produce IFN-a in response to
CpGA, live and HI- IAV (Fig. 2B). Interestingly, all cord blood
samples responded to IAV or HIV, whereas several samples were
unresponsive to CpGA as observed with both WB and isolated
pDC stimulation. Indeed, we observed a lack of cell survival in
several neonatal pDCs samples treated with CpGA that was not
observed following viral stimulation (Fig. 3A). Non responders and
low responders to CpGA for IFN-a (,100 pg/ml) was associated
with poor cell survival (Fig. 3A). This phenomenon may come
from the defective signaling observed by others [13]. In line with
this, cord blood pDC may require stronger signaling to survive
Figure 3. Survival fate of neonatal pDC following CpG activation. (A) IFN-a responses of neonatal pDCs to CpGA were plotted against the
survival rate. Cell survival is shown by annexin V and propidium iodide staining (PI). (B) Neonatal pDCs were stimulated with CpGA or IAV in the
absence or presence of IL-3 (10 ng/ml) or GMCSF (10 ng/ml) for 24 hrs. IFN-a was detected from supernatants.
doi:10.1371/journal.pone.0052003.g003
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which CpGA stimulation cannot fully provide, although this was
only observed in about 15% of samples. Any correlation could be
made with the mode of birth delivery (natural delivery vs.
caesarian), the gestational age at birth, or the sex of the neonate
(Fig. S2). Alternatively, some unknown factor(s) related to
development may render neonatal pDCs slightly more vulnerable
to apoptosis. The underlying mechanism awaits further investiga-
tion. Cell survival as well as IFN-a and TNF-a secretion (Fig. 2B)
were restored by adding IL-3 [19] or GM-CSF [20] as survival
factors. In contrast to previous reports [18], we failed to detect
unresponsive pDCs during HSV/TLR9 stimulation, as both
neonatal MNC and purified pDCs produced IFN-a to HSV-1
stimulation (Fig. 1A) indicating that the unresponsive phenotype is
not associated with a defective TLR9 pathway in cord pDCs. Our
results are supported by an earlier report in which both cord blood
and fetal liver pDCs responded normally to HSV stimulation by
producing high amount of IFN-a [21]. In addition, this report also
provided strong evidence that at earlier developmental stage pDCs
expressing CD34 already have the capacity to produce IFN-a in
response to HSV [21].
Mouse pDCs are clearly described for the production of both
IFN-a and IL-12 following TLR7/9 activation by viruses and
synthetic agonists. Human pDCs seem to be much more restricted
in their antiviral responses by producing IFN-a but not IL-12 [22].
Nevertheless, a small fraction of mature pDC can produce IL12
but not IFN-a [23]. Recently, CD2 was highlighted as a potential
Figure 4. Heterogeneity of neonatal pDCs. (A) The percentages CD123hiBDCA2+ pDCs within CD45+ MNC were calculated from neonatal cord
blood and adults. pDCs could be subdivided by CD2 and CD5, and the accumulated data for CD2+, CD2- pDCs subsets and CD2+CD5+, CD2+CD52
pDCs subsets are shown in (B). (C) The innate IFN-a production of sorted CD2+ and CD22 pDCs subsets to CpGA, live IAV and HIV (the results are
incated as ng/ml). (D) Neonatal and Adult MNCs were stimulated as indicated and CD2+CD5+, CD2+CD52 and CD22CD52 pDCs subsets were gated to
analyze their capacity to produce IFN-a detected by intracellular cytokine staining. Numbers indicate the percentage of cytokine-producing cells
among gated cells. Data are representative of 5 experiments. The number of donors is indicated for each group (n) as well as P values for adults and
neonates comparison.
doi:10.1371/journal.pone.0052003.g004
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marker for human pDCs subsets [24], and CD2+pDCs were
shown to produce IL-12p40 in addition to other properties
including IFN-a production. Importantly, the frequency of CD2+
and CD2- pDCs differed markedly between neonates and adult
(Fig. 4A and B), therefore we assessed the capacity of both subsets
to respond to CpGA or IAV and HIV viruses (Fig. 4C and D).
Both neonatal and adult pDCs subsets similarly produced IFN-a.
Non responders to CpGA was not associated with a particular
subset and could respond to HIV and IAV (Fig. 4C). We further
investigated IL-12p40 production by CD2+ vs. CD2- pDCs,
however we identified among CD2+pDCs that only a minor
population expressing CD5 did produce IL-12p40 in response to
CpGA and to HI-IAV (Fig. 5A). Steady state CD5+CD2+ pDC
produced much less IFN-a following TLR activation as compared
to other pDC subsets (Fig. 4D). These results are in agreement
with the dichotomy between IFN-a and IL-12 producing cells
[23]. Interestingly, CD5+CD2+ pDC at steady state have a
mature phenotype with increased CD86 and HLADR expression
as compared to other pDCs (Fig. 5B) and thus probably more
prone to play antigen-presenting cell functions. Again no
difference was observed between neonatal and adult pDCs. IL-
12p40 was not induced in myeloid DC and monocytes following
CpGA activation (Fig. 5A) in accordance with the lack of TLR 9
expression in these cells [25]. IL-12p70 and IL-23 were not
detected in agreement with previous studies [22]. IL-12p40 has
been suggested to be a chemoattractant for macrophages in the
context of bacterial infection, whether it may play a similar
function in viral infection or in antigen-presenting cell related
functions of pDCs remains to be clarified [26,27]. Altogether,
these results show that neonatal pDCs potently produce IFN-a in
response to live and inactivated viruses. Recent publications
highlighted the age dependent maturation of TLR responses
[4,28]. We provide evidence that this is not the case at the level of
antiviral responses of isolated pDC and for bulk mononuclear cells
for a variety of viruses. This points out the fact that age-dependent
maturation may not occur at the level of innate cells, but may
rather be controlled at the level of their environment to express
optimal functions. Therefore, age-dependent regulatory phenom-
enon rather than innate deficiencies should be considered for
limited inflammatory responses and susceptibility to infections seen
in earlylife. We demonstrated that neonatal pDCs can potently
participate in innate immunity in the context of viral infection,
indicating that pDCs do not contribute to early life susceptibility to
infections.
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